Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm

08 Nov 2024 16:45 CET

Nasdaq Stockholm has today notified Carasent AB (publ) ("Carasent" or the
"Company") of its assessment that the Company fulfills Nasdaq Stockholm's
listing requirements. Nasdaq Stockholm will approve an application for
admission to trading of the Company's shares, subject to the fulfilment of
certain customary conditions, including the approval and registration of a
prospectus by the Swedish Financial Supervisory Authority.

As announced on 30 August 2024 the Carasent ASA board of directors resolved on
a cross-border merger plan to effect the planned relisting of its shares on
Nasdaq Stockholm. Carasent ASA's Extraordinary General Meeting approved the
merger plan on 4 October 2024 as previously announced. The cross-border merger
is expected to be completed on 4 December 2024, upon which shareholders will
have their shares in Carasent ASA one for one exchanged with shares in
Carasent.

The last day of trading on Oslo Børs is expected to be 4 December 2024 and the
first day of trading on Nasdaq Stockholm is expected to be 9 December 2024.
The dates can be changed and if so, this will be announced in a stock exchange
announcement.

Shareholders in Carasent ASA are recommended to contact their bank to make
sure that their accounts can hold Swedish listed shares ahead of the
relisting. For further information please see https://carasent.com/investors
and https://www.nordnet.no/no/kampanjer/carasent.

For further information, please contact

Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

More information:
Access the news on Oslo Bors NewsWeb site

631755_Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm.pdf